Chemoinformaics analysis of 3-Methyl-3-pentanol
| Molecular Weight | 102.177 | nRot | 2 |
| Heavy Atom Molecular Weight | 88.065 | nRig | 5 |
| Exact Molecular Weight | 102.104 | nRing | 0 |
| Solubility: LogS | -5.179 | nHRing | 0 |
| Solubility: LogP | 5.24 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 20.1571 |
| nHD | 1 | BPOL | 14.0449 |
| QED | 0.574 |
| Synth | 1.786 |
| Natural Product Likeliness | -0.201 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.01 |
| HIA | 0.002 |
| CACO-2 | -4.402 |
| MDCK | 0.0000146 |
| BBB | 0.363 |
| PPB | 0.973076 |
| VDSS | 2.55 |
| FU | 0.0203147 |
| CYP1A2-inh | 0.971 |
| CYP1A2-sub | 0.545 |
| CYP2c19-inh | 0.828 |
| CYP2c19-sub | 0.094 |
| CYP2c9-inh | 0.639 |
| CYP2c9-sub | 0.834 |
| CYP2d6-inh | 0.07 |
| CYP2d6-sub | 0.168 |
| CYP3a4-inh | 0.142 |
| CYP3a4-sub | 0.193 |
| CL | 7.284 |
| T12 | 0.338 |
| hERG | 0.151 |
| Ames | 0.025 |
| ROA | 0.302 |
| SkinSen | 0.749 |
| Carcinogencity | 0.293 |
| EI | 0.993 |
| Respiratory | 0.902 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.956165 |